Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary movement disorders].

J B Schulz1,

  • 1Abt. für Neurodegeneration und Neurorestaurationsforschung, Zentren für Molekularphysiologie des Gehirns (CMPB) und Neurologische Medizin, Universitätsmedizin Göttingen, Göttingen, BRD. jschulz4@gwdg.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|December 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Unusual Presentation of Peri-Lead Edema Following Deep Brain Stimulation for Parkinson's Disease: A Case Report and Review of the Literature.

Clinical case reports·2025
Same author

Modulating the cholinergic system-Novel targets for deep brain stimulation in Parkinson's disease.

Journal of neurochemistry·2024
Same author

Gait improvement by high-frequency stimulation of the subthalamic nucleus in Parkinsonian mice is not associated with changes of the cholinergic system in the pedunculopontine nucleus.

Neuroscience letters·2023
Same author

Causes of Death in Endovascularly Treated Patients with Acute Stroke.

AJNR. American journal of neuroradiology·2022
Same author

[ZSE-DUO - dual guidance structure at the centre for rare diseases].

Innere Medizin (Heidelberg, Germany)·2022
Same author

Endovascular stroke treatment does not preclude high thrombolysis rates.

European journal of neurology·2018
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Legal and societal aspects of doping in sport].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[The institutionalisation of infection prevention and control in Germany: challenges since the "Gründerzeit" : A retrospect of over 50 years of KRINKO].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping in chess].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Effects of the cannabis act on supply channels, attitudes, and perceptions of users].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Hereditary movement disorders are genetic conditions affecting movement control, leading to disability and reduced lifespan. The German Network of Hereditary Movement Disorders (GeNeMove) aims to advance research and clinical care for these rare diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Rare Diseases

Context:

  • Hereditary movement disorders encompass a spectrum of genetically defined conditions.
  • These disorders significantly impact patient quality of life and life expectancy.
  • They serve as valuable models for understanding more common neurodegenerative diseases like Alzheimer's and Parkinson's.

Purpose:

  • To coordinate basic and clinical research into rare hereditary movement disorders.
  • To enhance collaboration among specialized German centers.
  • To improve the diagnosis, treatment, and understanding of these conditions.

Summary:

  • GeNeMove focuses on standardizing symptom documentation and disease progression tracking.
  • Development of clinical rating scales, therapeutic guidelines, and improved genetic testing are key objectives.

Related Experiment Videos

  • Establishment of biobanks for DNA, tissue, CSF, and blood samples from affected individuals is crucial for research.

    • Impact:

    • Facilitates standardized data collection for rare hereditary movement disorders.
    • Promotes advancements in genetic research and diagnostic capabilities.
    • Supports the development of targeted therapies and improved patient management strategies.